Achieve Life Sciences, Inc. Reimbursement Revenue (Deprecated 2018-01-31)
Achieve Life Sciences, Inc. (ACHV) reported Reimbursement Revenue (Deprecated 2018-01-31) of $5.06 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-23.
Discontinued › Income Statement › Other Income
us-gaap:ReimbursementRevenue · last filed 2017-07-31
- Achieve Life Sciences, Inc. reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- Achieve Life Sciences, Inc. reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- Achieve Life Sciences, Inc. reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2016-06-30 was $2.12M, a 47.28% decline year-over-year.
- Achieve Life Sciences, Inc. reimbursement revenue (deprecated 2018-01-31) for the quarter ending 2016-03-31 was $2.94M, a 113.97% increase year-over-year.
- Achieve Life Sciences, Inc. reimbursement revenue (deprecated 2018-01-31) for fiscal 2016 was $5.06M, a 72.13% decline from fiscal 2015.
- Achieve Life Sciences, Inc. reimbursement revenue (deprecated 2018-01-31) for fiscal 2015 was $18.16M, a 33.03% decline from fiscal 2014.
- Achieve Life Sciences, Inc. reimbursement revenue (deprecated 2018-01-31) for fiscal 2014 was $27.12M.
| Period end | Reimbursement Revenue (Deprecated 2018-01-31) 3 month | Reimbursement Revenue (Deprecated 2018-01-31) 6 month | Reimbursement Revenue (Deprecated 2018-01-31) 9 month | Reimbursement Revenue (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $0.00 derived: sum of 2 quarters · filed 2017-02-23 | $2.12M derived: sum of 3 quarters · filed 2017-07-31 | $5.06M 10-K · filed 2017-02-23 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-10 | $2.12M derived: sum of 2 quarters · filed 2017-07-31 | $5.06M 10-Q · filed 2016-11-10 | $11.09M derived: sum of 4 quarters · filed 2017-07-31 |
| 2016-06-30 | $2.12M 10-Q · filed 2017-07-31 | $5.06M 10-Q · filed 2017-07-31 | $11.09M derived: sum of 3 quarters · filed 2017-07-31 | $17.82M derived: sum of 4 quarters · filed 2017-07-31 |
| 2016-03-31 | $2.94M 10-Q · filed 2017-05-15 | $8.96M derived: sum of 2 quarters · filed 2017-05-15 | $15.70M derived: sum of 3 quarters · filed 2017-05-15 | $19.73M derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $6.02M 10-K · filed 2017-02-23 | $12.76M derived: sum of 2 quarters · filed 2017-02-23 | $16.79M derived: sum of 3 quarters · filed 2017-02-23 | $18.16M 10-K · filed 2017-02-23 |
| 2015-09-30 | $6.74M 10-K · filed 2017-02-23 | $10.76M derived: sum of 2 quarters · filed 2017-02-23 | $12.14M 10-Q · filed 2016-11-10 | |
| 2015-06-30 | $4.03M 10-K · filed 2017-02-23 | $5.40M 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | $1.37M 10-K · filed 2017-02-23 | |||
| 2014-12-31 | $27.12M 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |